We. Workman et Ra. Clayton, MICROBIAL STERILITY TESTING OF OIL-FORMULATED BOVINE SOMATOTROPIN USING TWEEN(R)-80 DISPERSION, Journal of pharmaceutical and biomedical analysis, 15(2), 1996, pp. 193-200
The Food and Drug Administration requires that sterile pharmaceutical
products be free of viable microorganisms. Sterility testing of pharma
ceutical products provides added assurance that the product is sterile
. Sterility testing is typically done by inoculating the drug product
into microbial growth media followed by visual inspection for growth d
uring incubation for a specified time period. A lack of visual growth
indicates that the drug product samples tested were sterile. Formulate
d Posilac(R) bovine somatotropin(1) consists of protein particles susp
ended in an oil-based excipient. The product formulation is immiscible
in aqueous media due to the excipient's water insolubility and the in
solubility of the protein particles at near neutral pH values. Because
the formulation is packaged and sold as a sterile product, it is crit
ical that a sensitive microbial sterility test method be used for this
key quality test. A sterility test method was developed for Posilac(R
) that utilized Tween(R) 80 (i.e. polysorbate 80) as a dispersant. Dis
persion of the product using Tween(R) 80 produced a homogeneous suspen
sion of bovine somatotropin particles and oil droplets in the micron s
ize range. The suspension did not appreciably settle out with time, at
testing to the homogeneous nature of the mixture. This method was foun
d to be compatible with survival, recovery, and growth from low number
s of the test organisms required by the U.S. Pharmacopeia XXIII as wel
l as from two additional test cultures.